NAD+
Cheap pills raise this natural cell fuel just fine. The expensive IV drips are mostly hype.
- What it is
- A coenzyme (a helper molecule) every cell uses to make energy
- Is it FDA-approved?
- Not as an injection. The pill forms (NR, NMN) are sold as supplements
- How strong is the proof?
- Pills clearly raise your blood levels. Whether you feel better is still argued
- How you take it
- Best as a pill: NR 250-1000 mg a day. Also sold as IV drips and shots
- Typical result
- Higher blood NAD+. Clear health wins are few so far
- Biggest catch
- IV 'loading' drips cost a fortune with no proof they beat cheap pills
Any word with a dotted underline is a science word — tap it for a plain-English meaning.
In plain words.
NAD+ is not a . It is a coenzyme. Think of it as a helper molecule every cell needs to make energy and fix DNA.
Your NAD+ levels drop as you get older. The idea behind taking it is to push those levels back up.
You usually do not take NAD+ itself. You take a building block your body turns into it. The two common ones are NR (nicotinamide riboside) and NMN. NR is still legally a supplement in the US. The FDA reclassified NMN as a drug in 2022, so its legal status is messier.
What people use it for.
People use it for energy, healthy aging, and recovery.
It is huge in the longevity world. You will see it pushed by famous longevity influencers.
Some people get it as an IV drip at a clinic, hoping for a quick boost. Others use a daily pill. The pill is the version with the real research behind it.
Does it actually work?
Half yes, half unproven. The pills (NR or NMN) clearly raise the NAD+ level in your blood. That part is solid, with 30+ human trials.
The catch is whether that higher level actually makes you feel better, age slower, or perform better. That is still being argued. Most trials show the blood number moves. Fewer show a real health win you would notice.
The amazing mouse results are real but have only partly carried over to people. So far it is more promise than proof.
what you’ve probably heard.
The claims floating around online, and how true they actually are.
“NAD+ drips reverse aging and make you feel decades younger.”
overblownThe pills clearly raise your blood NAD+, but whether a higher level actually slows aging or makes you feel better is still being argued. The movie-trailer version is marketing.
“IV drips work way better than cheap pills.”
noThere is no real evidence the drip beats a daily NR pill. The pill is the form with 30-plus human trials behind it, while the IV 'loading' package mostly pays the clinic's rent.
“An NAD+ IV drip gives you a big energy boost.”
half trueYour cells do use NAD+ to make energy, but a day-to-day lift you would actually notice from a drip is not something the trials reliably show. The pill raises your blood level for a fraction of the price.
“The burning during a NAD+ shot means something is wrong with the batch.”
mythThat burn is just the molecule itself under the skin. It does not mean the vial is strong, weak, or contaminated.
How you take it.
The best-studied way is a pill. Take NR, 250 to 1000 mg a day, for at least 8 to 12 weeks. That is the dose that reliably raises your blood NAD+. For most people, NR around 250 to 500 mg a day is a fine start.
Clinics also sell IV drips and shots, but those cost far more for no proven extra benefit.
One heads-up on shots: NAD+ given under the skin burns at the spot for a few minutes. That burn is the molecule itself. It does not mean your batch is bad or infected.
What to watch out for.
The common stuff
The pills are well tolerated. The injected and IV forms can cause flushing, nausea, or a burning feeling if pushed too fast. Going slower fixes most of that.
The serious stuff
The bigger risk here is to your wallet, not your body. IV clinics sell "loading" packages of 5 to 10 sessions at $300 to $1,500 each. There is no real evidence that pattern beats cheap daily pills. That is how the clinic pays its rent.
If you have an active cancer, talk to your doctor first. NAD+ pathways can feed cancer cells in ways no one fully understands. We are not your doctor.
Where people get it.
Here are the common ways people get it.
- Pills (NR or NMN). Sold over the counter as supplements. Cheapest and best-studied. Pick a brand that publishes lab tests on its batches. The most-studied NR line is the Niagen one.
- IV drip or clinic shot. From $200 to $1,500 a month depending on the route. Fine for a tele-clinic shot. Markup-heavy for the IV "loading" packages.
- Research-only () injectable. About $60–$200 a month. Sold "for research only." If it was pre-mixed more than 30 days ago, it has likely gone weak. NAD+ breaks down in liquid.
A common supplement scam: a "proprietary blend" label that hides how much NR or NMN you actually get. If the bottle will not tell you the milligrams, you cannot match the studied dose. Skip it.
Our honest take.
The cheap pills work; the IV-drip ritual has a big marketing budget the science does not support.
If you want to test the idea, run oral NR at a researched dose for 12 weeks. Judge it by your labs and how you actually feel, and stop if nothing changes. Just do not pay clinic prices for it: a daily pill costs a tiny fraction of the $300-a-session drips, with no evidence the drip does anything extra.
It will not hurt most people. Just do not expect the movie-trailer results the clinics promise.
The studies behind this.
We read the research so you don't have to. Here's where the facts on this page come from.
- 01Xue X, et al. Nicotinamide adenine dinucleotide metabolism: driving or counterbalancing inflammatory bowel disease?. FEBS letters. 2023;597(9):1179-1192. PMID: 36310388.
- 02Yu F, et al. Nicotinamide Adenine Dinucleotide Supplementation to Alleviate Heart Failure: A Mitochondrial Dysfunction Perspective. Nutrients. 2025;17(11). PMID: 40507126.
- 03Bi YW, et al. Nicotinamide adenine dinucleotide phosphate oxidase in pancreatic diseases: Mechanisms and future perspectives. World journal of gastroenterology. 2024;30(5):429-439. PMID: 38414585.
- 04Navas LE, et al. Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer. Cells. 2022;11(17). PMID: 36078035.
- 05Shen J, et al. Nicotinamide adenine dinucleotide phosphate oxidase activation and neuronal death after ischemic stroke. Neural regeneration research. 2019;14(6):948-953. PMID: 30761998.
- 06Lin Y, et al. Nicotinamide Adenine Dinucleotide-Loaded Lubricated Hydrogel Microspheres with a Three-Pronged Approach Alleviate Age-Related Osteoarthritis. ACS nano. 2025;19(18):17606-17626. PMID: 40315404.
- 07Hosseini L, et al. Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions. Biogerontology. 2019;20(4):381-395. PMID: 30838484.
- 08Griffiths HBS, et al. Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target. Biochemical Society transactions. 2020;48(3):733-744. PMID: 32573651.
- 09Kang S, et al. Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD(+)) by Synergistic Inhibition of CD38 Expression. Cells. 2024;13(21). PMID: 39513906.
- 10Mortezaee K. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review. Cell biochemistry and function. 2018;36(6):292-302. PMID: 30028028.
- 11Pollard CL. Can Nicotinamide Adenine Dinucleotide (NAD(+)) and Sirtuins Be Harnessed to Improve Mare Fertility?. Animals : an open access journal from MDPI. 2024;14(2). PMID: 38254361.
- 12Zhou ZD, et al. Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson's disease. Ageing research reviews. 2020;62:101107. PMID: 32535274.
- 13Fan L, et al. Impaired nicotinamide adenine dinucleotide (NAD(+) ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment. Journal of diabetes investigation. 2020;11(6):1403-1419. PMID: 32428995.
- 14Fujita H, et al. Novel insight into nicotinamide adenine dinucleotide and related metabolites in cancer patients undergoing surgery. Scientific reports. 2024;14(1):16557. PMID: 39019993.
- 15Gansemer ER, et al. Pathways Linking Nicotinamide Adenine Dinucleotide Phosphate Production to Endoplasmic Reticulum Protein Oxidation and Stress. Frontiers in molecular biosciences. 2022;9:858142. PMID: 35601828.
- 16Sugishita Y, et al. Nicotinamide Adenine Dinucleotide (NAD)-Dependent Protein Deacetylase, Sirtuin, as a Biomarker of Healthy Life Expectancy: A Mini- Review. Current aging science. 2025;18(2):95-101. PMID: 39377386.
- 17Zhang X, et al. The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential. Genes & diseases. 2021;9(4):959-972. PMID: 35685463.
- 18Poyan Mehr A, et al. PPARγ-Coactivator-1α, Nicotinamide Adenine Dinucleotide and Renal Stress Resistance. Nephron. 2017;137(4):253-255. PMID: 28591759.
- 19Mericskay M. Nicotinamide adenine dinucleotide homeostasis and signalling in heart disease: Pathophysiological implications and therapeutic potential. Archives of cardiovascular diseases. 2016;109(3):207-15. PMID: 26707577.
- 20Lin H. Nicotinamide adenine dinucleotide: beyond a redox coenzyme. Organic & biomolecular chemistry. 2007;5(16):2541-54. PMID: 18019526.
- 21Colombo G, et al. Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer. Frontiers in pharmacology. 2021;12:758320. PMID: 34880756.
- 22Penberthy WT. Nicotinamide adenine dinucleotide biology and disease. Current pharmaceutical design. 2009;15(1):1-2. PMID: 19149596.
- 23Song S, et al. Nicotinamide Adenine Dinucleotide Supplementation Improves Cuprizone-Induced Multiple Sclerosis-Related Behavioral Changes in C57BL/6J Mice. Brain and behavior. 2025;15(5):e70525. PMID: 40320991.
- 24Palmer RD, et al. Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging. Aging medicine (Milton (N.S.W)). 2021;4(3):214-220. PMID: 34553119.
- 25Pospieszna B, et al. Erythrocyte nicotinamide adenine dinucleotide concentration is enhanced by systematic sports participation. BMC sports science, medicine & rehabilitation. 2024;16(1):216. PMID: 39407226.
- 26Ferro V, et al. NAD(+) (nicotinamide adenine dinucleotide, oxidized form). Trends in endocrinology and metabolism: TEM. 2025;36(3):292-293. PMID: 39266435.
- 27Harijith A, et al. The Role of Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Lung Architecture Remodeling. Antioxidants (Basel, Switzerland). 2017;6(4). PMID: 29257052.
- 28Pei Z, et al. Nicotinamide Adenine Dinucleotide in the Development and Treatment of Cardiac Remodeling and Aging. Mini reviews in medicinal chemistry. 2022;22(18):2310-2317. PMID: 35249481.
- 29Xia X, et al. Nicotinamide adenine dinucleotide rejuvenates septic bone marrow mesenchymal stem cells. World journal of stem cells. 2025;17(2):96893. PMID: 40061269.
- 30Lu W, et al. Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors. Antioxidants & redox signaling. 2018;28(3):167-179. PMID: 28497978.
- 31Wang H, et al. Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific Effects. Antioxidants (Basel, Switzerland). 2017;6(2). PMID: 28587189.
- 32Kahn B, et al. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction. Journal of drugs in dermatology : JDD. 2022;21(10):1129-1132. PMID: 36219044.
- 33Parikh SM. Metabolic Stress Resistance in Acute Kidney Injury: Evidence for a PPAR-Gamma-Coactivator-1 Alpha-Nicotinamide Adenine Dinucleotide Pathway. Nephron. 2019;143(3):184-187. PMID: 31055583.
- 34Rodriguez Cetina Biefer H, et al. Aspects of Tryptophan and Nicotinamide Adenine Dinucleotide in Immunity: A New Twist in an Old Tale. International journal of tryptophan research : IJTR. 2017;10:1178646917713491. PMID: 28659716.
- 35Huang Y, et al. Evaluating Nicotinamide Adenine Dinucleotide for Its Effects on Halo Blight of Snap Bean. Plant disease. 2023;107(3):675-681. PMID: 35881875.
- 36Liu X, et al. Impaired Nicotinamide Adenine Dinucleotide Biosynthesis in the Kidney of Chronic Kidney Disease. Frontiers in physiology. 2021;12:723690. PMID: 34603081.
- 37Liao C, et al. Nicotinamide adenine dinucleotide attenuates acetaminophen-induced acute liver injury via activation of PARP1, Sirt1, and Nrf2 in mice. Canadian journal of physiology and pharmacology. 2022;100(8):796-805. PMID: 35983933.
- 38Chakrabarti G, et al. Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways. Clinical pharmacology : advances and applications. 2015;7:57-68. PMID: 25870517.
- 39Yamaguchi S, et al. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men. Endocrine journal. 2024;71(2):153-169. PMID: 38191197.
- 40Liu XY, et al. Nicotinamide adenine dinucleotide promotes synaptic plasticity gene expression through regulation N-methyl-D-aspartate receptor/Ca(2+)/Erk1/2 pathway. The Chinese journal of physiology. 2021;64(6):266-273. PMID: 34975119.
- 41Song Y, et al. Genome Analysis of Nicotinamide Adenine Dinucleotide-Independent Mycoplasma synoviae Isolates From Korea. Pathogens (Basel, Switzerland). 2021;10(10). PMID: 34684178.
- 42Lees JG, et al. Nicotinamide adenine dinucleotide induces a bivalent metabolism and maintains pluripotency in human embryonic stem cells. Stem cells (Dayton, Ohio). 2020;38(5):624-638. PMID: 32003519.
- 43Ryu CH, et al. Nicotinamide adenine dinucleotide phosphate oxidase inhibitor induces apoptosis on Epstein-Barr virus positive B lymphoma cells. Anatomy & cell biology. 2020;53(4):471-480. PMID: 33361545.
- 44Kirkland JB, et al. Niacin. Advances in food and nutrition research. 2018;83:83-149. PMID: 29477227.
- 45Kuerec AH, et al. Association between blood nicotinamide adenine dinucleotide levels and blood laboratory parameters at baseline and after nicotinamide mononucleotide supplementation in middle-aged healthy individuals: post hoc analysis of a randomized, double-blinded, placebo-controlled clinical trial. GeroScience. 2025. PMID: 41162813.
- 46Anithaa AC, et al. Nicotinamide adenine dinucleotide immobilized tungsten trioxide nanoparticles for simultaneous sensing of norepinephrine, melatonin and nicotine. Biosensors & bioelectronics. 2019;143:111598. PMID: 31442753.
- 47Liu J, et al. A Targeting Senescence and Recycling Intracellular Nicotinamide Adenine Dinucleotide Strategy for Attenuation of Senescence-Associated Phenotypes. ACS nano. 2025;19(36):32131-32144. PMID: 40911860.
- 48Merk V, et al. pH-Dependent Flavin Adenine Dinucleotide and Nicotinamide Adenine Dinucleotide Ultraviolet Resonance Raman (UVRR) Spectra at Intracellular Concentration. Applied spectroscopy. 2021;75(8):994-1002. PMID: 34076541.
- 49Arias-Mendoza F, et al. Assessment of Nicotinamide Adenine Dinucleotide in Human Tissues by In Vivo Phosphorus-31 Magnetic Resonance Spectroscopic Imaging at 1.5 Tesla. Advances in experimental medicine and biology. 2022;1395:323-328. PMID: 36527656.
- 50Tsurho V, et al. A zebrafish model of nicotinamide adenine dinucleotide (NAD(+)) deficiency-derived congenital disorders. bioRxiv : the preprint server for biology. 2025. PMID: 39829932.
- 51Prasanna J, et al. Role of nicotinamide adenine dinucleotide in cardiovascular disease. Current opinion in cardiology. 2026. PMID: 42047243.
- 52Cheng L, et al. A novel nicotinamide adenine dinucleotide control strategy for increasing the cell density of Haemophilus parasuis. Biotechnology progress. 2019;35(3):e2794. PMID: 30816004.
- 53Otsuka-Yamasaki Y, et al. Characterization of a novel nicotinamide adenine dinucleotide-cytochrome b5 reductase mutation associated with canine hereditary methemoglobinemia. The Journal of veterinary medical science. 2021;83(2):315-321. PMID: 33342963.
- 54Ministrini S, et al. A Liposomal Formulation Enhances the Anti-Senescence Properties of Nicotinamide Adenine-Dinucleotide (NAD(+)) in Endothelial Cells and Keratinocytes. Current issues in molecular biology. 2025;47(9). PMID: 41020844.
- 55WINER AD. CRYSTALLIZATION OF NICOTINAMIDE ADENINE DINUCLEOTIDE. The Journal of biological chemistry. 1964;239:PC3598+. PMID: 14245423.
- 56Matsuyama R, et al. Stabilization and quantitative measurement of nicotinamide adenine dinucleotide in human whole blood using dried blood spot sampling. Analytical and bioanalytical chemistry. 2023;415(5):775-785. PMID: 36504284.
- 57Liu L, et al. Exogenous nicotinamide adenine dinucleotide administration alleviates ischemia/reperfusion-induced oxidative injury in isolated rat hearts via Sirt5-SDH-succinate pathway. European journal of pharmacology. 2019;858:172520. PMID: 31278893.
- 58Liu Y, et al. [Glucose Metabolism-Derived Nicotinamide Adenine Dinucleotide Phosphate in Late-Onset Preeclampsia Placenta Tissue and Its Correlation with Oxidative Stress]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition. 2022;53(6):1028-1032. PMID: 36443047.
- 59Chaffin WL, et al. Nicotinamide adenine dinucleotide metabolism in Candida albicans. Journal of bacteriology. 1979;139(3):883-8. PMID: 225302.
- 60Eller J, et al. Improved Yield for the Enzymatic Synthesis of Radiolabeled Nicotinamide Adenine Dinucleotide. ACS bio & med chem Au. 2023;3(1):46-50. PMID: 36820310.
Learn about these too.
We're not your doctor, and this isn't medical advice. It's a plain-English summary of what the research says, so you can have a smarter conversation with someone who is.
Want the rest of the peptide world, in plain English?
New breakdowns, safety updates, and what's actually worth your money. Free. Unsubscribe in one click.